A study of the survival benefit of lymphadenectomy with radical surgery for the patients with urothelial carcinoma - A prospective study of extended lymphadenectomy-

A study of the survival benefit of lymphadenectomy with radical surgery for the patients with urothelial carcinoma - A prospective study of extended lymphadenectomy- - A prospective study of lymphadenectomy for urothelial carcinoma of the upper urinary tract

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001940

Enrollment

100

Registered

2010-04-01

Start date

2005-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

urothelial carcinoma of the upper urinary tract urothelial carcinoma of the bladder

Interventions

extended lymphadenectomy (complete dissection of regional lymph nodes)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: the patients without severe co-mobidity, with urothelial carcinoma and without distant metastasis

Exclusion criteria

Exclusion criteria: the patients considered inelegible for this study the patients with non-urothelial carcinoma

Design outcomes

Primary

Measure	Time frame
cancer-specific survival	—

Secondary

Measure	Time frame
intravesical recurrence disease-free survival overall survival	—

Countries

Japan

Contacts

Public ContactTsunenori Kondo

Tokyo Women's Medical University Urology

tkondo@kc.twmu.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026